Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:30 PM
Ignite Modification Date:
2025-12-24 @ 10:30 PM
NCT ID:
NCT00857935
Eligibility Criteria:
Inclusion Criteria:
* Male or female, 6 months of age or older
* Subject must have a head lice infestation present at baseline
* Subject/caregiver must read English or Spanish at a 7th grade level
* Subject must have an appropriately signed Informed Consent agreement
* Other members of the household with a lice infestation must be willing to be enrolled in the study or treat their infestations with a standard treatment
* Subject agreement to not use any other form of lice treatment during the course of the study
* Subject agreement to not cut or chemically treat their hair in the period between baseline and final, post-treatment visits
Exclusion Criteria:
* Individuals with a history of irritation or sensitivity to pediculicides or hair care products
* Individuals with any visible skin/scalp condition at the treatment site that could interfere with the evaluation
* Individuals previously treated with a pediculicide or any other head lice treatment product within 48 hours prior to enrollment
* Individuals receiving systemic or topical drugs that may interfere with the study results
* Individuals who have participated in a clinical trial within 30 days of enrollment
* Individuals with family members who are infested with lice but are unwilling or unable to enroll in the study or to use the standard course of lice treatment
* Females who are pregnant or nursing
* Sexually-active females not using effective contraception
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
6 Months
Study:
NCT00857935
Study Brief:
Protocol Section:
NCT00857935